Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Pancreatic Neoplasms 15Neoplasms 11Multiple Myeloma 9Colorectal Neoplasms 8Myelodysplastic Syndromes 7Leukemia, Myeloid, Acute 6Glioblastoma 5Sarcoma 4Prostatic Neoplasms 4Neoplasms, Plasma Cell 4Leukemia, Myelomonocytic, Chronic 4Carcinoma, Non-Small-Cell Lung 4Inflammation 3Breast Neoplasms 3Stomatitis 2Stomach Neoplasms 2Skin Neoplasms 2Primary Myelofibrosis 2Ovarian Neoplasms 2Neoplasms by Site 2Myofibroma 2Myeloproliferative Disorders 2Lymphoma 2Lung Neoplasms 2Liver Neoplasms 2Leukemia 2Glioma 2Frailty 2Digestive System Neoplasms 2Digestive System Diseases 2

Interventions

Temozolomide 61Radiotherapy 25Bevacizumab 21Magnetic Resonance Spectroscopy 20Irinotecan 18Filgrastim 15Carboplatin 15Carmustine 11Surgical Procedures, Operative 10Etoposide 9antineoplaston AS 2-1 8antineoplaston A10 8Specimen Handling 8sargramostim 7Radiation 7Peripheral Blood Stem Cell Transplantation 7Everolimus 7Biopsy 7Vincristine 6Radiotherapy, Intensity-Modulated 6Procarbazine 6O(6)-benzylguanine 6Erlotinib Hydrochloride 6Topotecan 5Melphalan 5Magnetic Resonance Imaging 5Lomustine 5Genetic Therapy 5Cyclophosphamide 5Aminolevulinic Acid 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Astrocytoma × Ascorbic Acid × Clear all
NCT02168270 2023-11-24

Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma

University of Nebraska

Phase 1 Terminated
4 enrolled 6 charts
CNSSarcoma

Astrocytoma, Glioblastoma, Oligodendroglioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡